Nova Ltd. Ordinary Shares (NVMI) Stock Analysis
Market Closed
Sector: Other
AnalystsStrong Buy15 analystsPrice History
5-Year Weekly Candlestick Chart
Profile
Strong growth, financial health, profitability and earnings quality; valuation lags behind.
How is each axis scored?
- Valuation15/100 · Weak
- P/E vs own history (69th pct)5/25
- FCF yield (1.6%)5/25
- P/S (13.3x)5/25
- EV/EBIT (45.0x)0/25
- Growth100/100 · Strong
- Revenue CAGR (20.6%)25/25
- Net income CAGR (29.2%)25/25
- EPS CAGR 5Y (26.4%)25/25
- Fwd implied growth (59.1%)25/25
- Profitability90/100 · Strong
- ROIC (16.1%)20/25
- ROE (17.7%)20/25
- Net margin (29.4%)25/25
- Operating margin (28.9%)25/25
- Financial Health93/100 · Strong
- Altman Z (7.94)25/25
- Current ratio (1.55)18/25
- Interest coverage (no interest expense)25/25
- Net cash / debt (Net cash)25/25
- Quality75/100 · Strong
- Piotroski F (5/9)15/25
- Beneish M (-2.27)20/25
- FCF conversion (73%)15/25
- Margin stability (σ 1.2%)25/25
About Nova Ltd. Ordinary Shares
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing. Show more
The company provides high-performance metrology solutions across the semiconductor fabrication lifecycle and develops differentiated inline metrology solutions deployed by a broad range of customers, including integrated circuit manufacturers. Its portfolio combines high-precision hardware and software, enabling customers to improve device performance, enhance yields, and accelerate time to market. Its products include Dimensional Metrology, Materials Metrology, Chemical Metrology, and Software Solutions. The company operates in China, Taiwan, R.O.C., the United States and other regions, with maximum revenue coming from China.
Employees: 1,612 · Website ↗
Insider Transactions
Recent SEC Form 4 filings
- SellOpen market sale · filed 2026-09-22-3864 sh2026-09-21
- SellOpen market sale · filed 2026-09-02-1500 sh2026-09-01
- BuyGrant / award · filed 2026-09-01+1.3K sh2026-09-01
- BuyGrant / award · filed 2026-09-01+1.3K sh2026-09-01
- SellOpen market sale · filed 2026-07-06-2966 sh2026-07-02
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
15EP/E (TTM)46.1xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 18.7x–76.1x · 69th pct
P/FCF60.5xD
Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield1.6%C
Grade C: LowTTM FCF / Market Cap — vs own 5Y history: 1.0%–5.3% · 14th pct
P/S (TTM)13.25xD
Grade D: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 4.6x–22.4x · 76th pct
EV/EBIT45.0xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 16.2x–76.7x · 70th pct
EV/Sales—
Enterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E29.0xC
Grade C: ExpensivePrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio7.96xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio2.30C
Grade C: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
90A+ROIC16.1%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE17.7%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA11.3%A
Grade A: StrongReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin29.4%A
Grade A: HighNet Income / Revenue
Operating Margin28.9%A
Grade A: HighTTM EBIT / TTM Revenue
Gross Margin57.4%A
Grade A: PremiumGross Profit / Revenue
FCF Margin21.5%A
Grade A: HighFCF / Revenue
True FCF Margin18.4%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
93A+Altman Z-Score7.94A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.55xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio5.40xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage—
EBIT/Interest. >10 Strong
Debt RepaymentNet CashA
Grade A: FastYears to repay net debt via FCF
Net Debt/EBITNet CashA
Grade A: LowLeverage. <2x Low, >4x High
Debt/Equity0.55xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt1.27xA
Grade A: CoveredCash covers how much of total debt. >1 = could repay all debt from cash
Growth
100A+Revenue CAGR20.6%A
Grade A: HighCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR29.2%A
Grade A: HighCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)26.4%A
Grade A: HighCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth59.1%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income10.7%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue3.1%C
Grade C: MedTTM stock-based comp / TTM Revenue
Quality
75B+Piotroski F-Score5/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.27A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion73.2%C
Grade C: AverageFCF / Net Income
Margin Stability1.2%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue2.6%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.46xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Per Share, Balance Sheet, MarketHide additional metrics
Per Share
EPS (TTM)$7.96
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$32.99
Cash & short-term investments per share (Finnhub)
Book Value / Share$41.48
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$803.50M
Total debt obligations (short + long term)
Cash & Equiv.$1.02B
Cash and short-term investments
Net Debt$-217.50MA
Grade A: Net CashTotal Debt minus Cash. Negative = Net Cash position
Total Equity$1.47B
Shareholders' equity (book value)
Asset / Liability2.43xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$11.67B
Current Market Capitalization
Beta1.83D
Grade D: High volatilityPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Company is effectively debt-free after netting cash. · Current P/E of 46.1x sits at the 69th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Dec 2025 · Ratio snapshot Sep 25, 2026
Key Insights: Nova Ltd. Ordinary Shares (NVMI)
Piotroski F-Score of 5/9 indicates mixed fundamentals for Nova Ltd. Ordinary Shares. Altman Z-Score of 7.94 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk. Beneish M-Score of -2.27 suggests a low likelihood of earnings manipulation. Revenue has compounded at roughly 21% annually, with net income growing about 29% per year — a strong growth profile.
- Nova Ltd. Ordinary Shares converts about 22% of revenue into free cash flow — strong cash generation.
- Company is effectively debt-free after netting cash.
- At a valuation score of 15/100, NVMI trades at a premium to its historical multiples (P/E 46.1).
See how NVMI ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for NVMI in the last 30 days.
See NVMI move history →Frequently Asked Questions about NVMI
Is NVMI stock a buy right now?
PreMarketPrice's quantitative model rates Nova Ltd. Ordinary Shares's financial health at 93/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is NVMI stock overvalued?
Nova Ltd. Ordinary Shares trades at a trailing P/E of 46.1 and our valuation score rates it 15/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Nova Ltd. Ordinary Shares report earnings?
No confirmed earnings date is currently scheduled for NVMI. The Earnings section lists recent reports and updates as dates are announced.
What sector does Nova Ltd. Ordinary Shares operate in?
Nova Ltd. Ordinary Shares operates in the Other sector. The Related Stocks section lists sector peers for comparison.
What does Nova Ltd. Ordinary Shares do?
Nova Ltd is a provider of metrology and process control solutions used in semiconductor manufacturing.
About Nova Ltd. Ordinary Shares (NVMI) Stock
Nova Ltd. Ordinary Shares (NVMI) is a US-listed stock operating in the Other sector. Real-time pricing data for Nova Ltd. Ordinary Shares is available on this page with a market capitalization of $11.7 billion. The financial health score for NVMI is 93/100, which indicates excellent financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for NVMI stock.
NVMI Stock Analysis & Key Metrics
On PreMarketPrice, you can track Nova Ltd. Ordinary Shares (NVMI) across multiple dimensions:
- Pre-market price & movement: Real-time NVMI stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for NVMI with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Nova Ltd. Ordinary Shares across multiple reporting periods.
- Financial health score: A composite score of 93/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for NVMI.
- Sector peers: Compare NVMI against 10 other other stocks on key financial metrics.
Is NVMI a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Nova Ltd. Ordinary Shares (NVMI) as an investment. The financial health score of 93/100 suggests excellent financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Nova Ltd. Ordinary Shares (NVMI) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.